Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 550-557

  Nagano, Hiroaki ^a   Mitchell, Richard N ^a   Taylor, Marta K ^a   Hasegawa, Satoru ^a   Tilney, Nicholas L ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Arteriosclerosis; Cardiac transplantation; IFN knockout mouse

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030809244     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119564     Document Type: Article

References (47)

1. Uretsky, B.F., S. Murali, P.S. Reddy, B. Rabin, A. Lee, B.P. Griffith, R.L. Hardesty, A. Trento, and H.T. Bahnson. 1987. Development of coronary artery disease in cardiac patients receiving immunosuppressive therapy with cyclosporin and prednisone. Circulation. 76:827-834.
2. Paul, L.C. and B. Fellstrom. 1992. Chronic vascular rejection of the heart and the kidney: have rational treatment options emerged? Transplantation (Baltimore). 53:1169-1179.
3. Hosenpud, J.D., G.D. Shipley, and C.R. Wagner. 1992. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J. Heart Lung Transplant. 11:9-23.
4. Russell, M.E., M. Fujita, M.A. Masek, R.A. Rowan, and M.E. Billingham. 1993. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation (Baltimore). 56:1599-1601.
5. Hauptman, P.J., S.F. Davis, L. Miller, and A.C. Yeung. 1995. The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. J. Heart. Lung. Transplant. 14:238s-242s.
6. Salomon, R.N., C.C.W. Hughes, F.J. Schoen, D.D. Payne, J.S. Pober, and P. Libby. 1991. Human coronary transplantation-associated arteriosclerosis. Am. J. Pathol. 138:791-798.
7. Dumont, F.J., R. Dijkmans, R.G.E. Palfee, R.D. Boldtz, and L. Coker. 1987. Selective up-regulation by interferon-γ of surface molecules of Ly-6 complex in resting T cells: the Ly-6A/E and TAP antigens are preferentially enhanced. Eur. J. Immunol. 17:1183-1191.
8. Barr, C., and G.F. Sanders. 1991. Interferon γ inducible regulation of the human invariant chain. J. Biol. Chem. 266:3475-3481.
9. 2-microglobulin gene expression in humal neuronal cells: factor binding to conserved cis-acting regulatory sequences correlates with expression of the gene. J. Immunol. 150:3300-3310.
10. Dustin, M.L., R. Rothelin, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction of IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
11. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science. (Wash. DC.) 259:1739-1742.
12. Corry, R.J., H.J. Winn, and P.S. Russell. 1973. Primary vascularized allografts of hearts in mice. Transplantation (Baltimore). 16:344-350.
13. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse heart. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. 144:260-274.
14. Smith, S.C., and P.M. Allen. 1992. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ. Res. 70:856-863.
15. Hsu, S.M., L. Raine, and H. Fanger. 1981. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am. J. Clin. Pathol. 75:816-821.
16. Billingham, M.E., N.R.B. Cary, M.E. Hammond, J. Kemnitz, C. Marboe, H.A. McCallister, D.C. Snovar, G.L. Winters, and A. Zerbe. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J. Heart. Lung. Transplant. 9:587-593.
17. Hruban, R.H., W.E. Beschorner, W.A. Baugarter, S.M. Augustine, H. Ren, B.A. Retz, and G.M. Hutchins. 1990. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am. J. Pathol. 137:871-887.
18. Tullius, S.G., and N.L. Tilney. 1995. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation (Baltimore). 59:313-318.
19. Libby, P., R.N. Salomon, D.D. Payne, F.J. Schoen, and J.S. Pober. 1989. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant. Proc. 21:3677-3684.
20. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-γ. Transplantation (Baltimore). 57: 1367-1371.
21. Gajewski, T.F., and F.W. Fitch. 1988. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245-4252.
22. Liu, Y., and C.A. Janeway, Jr. 1990. Interferon-γ plays a critical role in induced cell death of effector T cell. A possible third mechanism of self-tolerance. J. Exp. Med. 172:1735-1739.
23. Bucy, R.P., D.W. Hanto, E. Berens, and R.D. Schreiber. 1988. Lack of an obligate role of IFN-γ in the primary in vitro mixed lymphocyte response. J. Immunol. 140:1148-1152.
24. Nathan, C.F., H.W. Murray, M.E. Wiebe, and B.Y. Rubin. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
25. Shi, C. W. Lee, Q. He, D. Zhang, D.L. Fletcher, Jr., J.B. Newell, and E. Harber. 1996. The immunological basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA. 93:4051-4056.
26. Russell, M.E., W.W. Hancock, E. Akalin, A.F. Wallace, T. Glysing-Jensen, T.A. Willet, and M.H. Sayegh. 1996. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97:833-838.
27. Rosa, F., and M. Fellous. 1984. The effect of gamma-interferon on MHC antigens. Immunol. Today. 5:261-262.
28. Skoskiewicz, M.J., R.B. Colvin, E.E. Schneeberger, and P.S. Russell. 1985. Wide spread and selective induction of major histocompatibility complex-determined antigens in vivo by γ interferon. J. Exp. Med. 162:1645-1664.
29. Pober, J.S., and M.A. Gimbrone, Jr. 1982. Expression of Ia-like antigens by human endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc. Natl. Acad. Sci. USA. 79: 6641-6645.
30. Pober, J.S., T. Collins, M.A. Gimbrone, Jr., P. Libby, and C.S. Reiss. 1986. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation (Baltimore). 41:141-146.
31. Mansson, G.K., L. Jonasson, J. Holm, M.M. Clowes, and A.W. Clowes. 1988. γ-Interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ. Res. 63:712-719.
32. Collins, T., L.A. Lapierre, W. Fiers, J.L. Strominger, and J.S. Pober. 1986. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B, antigens in vascular endothelial cells and dermal fibroblasts in vivo. Proc. Natl. Acad. Sci. USA. 83:446-450.
33. Collins, T., A.J. Korman, C.T. Wake, J.M. Boss, D.J. Kappes, W. Fiers, K.A. Ault, M.A. Gimbrone, Jr., J.L. Storominger, and J.S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA. 81:4917-4921.
34. Goes, N., J. Urmson, M. Hobart, and P.F. Halloran. 1996. The unique role of interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation (Baltimore). 62:1889-1894.
35. Misinovski, B., D. Urdal, and W.M. Gallatin. 1990. IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J. Immunol. 145:2886-2895.
36. Thornhill, M.H., S.M. Wellicome, D.L. Mahiouz, J.S.S. Lanchbury, U. Kyan-Aung, and D.O. Haskard. 1991. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cells for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J. Immunol. 146:592-598.
37. Thornhill, M.H., and D.O. Haskard. 1990. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J. Immunol. 145:865-872.
38. Thornhill, M.H., U. Kyan-Aung, and D.O. Haskard. 1990. IL-4 increases human endothelial adhesiveness for T cells but not for neutrophils. J. Immunol. 144:3060-3065.
39. Pober, J.S., M.A. Gimbrone, Jr., L.A. Lapierre, D.L. Mendrick, W. Fiers, R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and murine interferon. J. Immunol. 137:1893-1896.
40. Ardehali, A., H. Laks, D.C. Drinkwater, E. Ziv, and T.A. Drake. 1995. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation. 92:450-456.
41. Tanaka, H., G.K. Sukhova, and P. Libby. 1994. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler. Thromb. 14:734-745.
42. Pelletier, R.P., R.G. Ohye, A. Vanbuskirk, D.D. Sedmak, P. Kincade, R.M. Ferguson, and C.G. Orosz. 1992. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J. Immunol. 149:2473-2481.
43. Orosz, C.G., R.G. Ohye, R.P. Pelletier, A. Vanbuskirk, E. Huang, C. Morgan, P. Kincade, and R.M. Ferguson. 1993. Treatment of anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance. Transplantation (Baltimore). 56:453-460.
44. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science (Wash. DC). 255:1125-1127.
45. Russell, P.S., C.M. Chase, and R.B. Colvin. 1995. Coronary atherosclerosis in transplanted mouse hearts. IV. Effects of treatment with monoclonal antibodies to intracellular adhesion molecule-1 and leukocyte function-associated antigen-1. Transplantation (Baltimore). 60:724-729.
46. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
47. Saleem, S., B.T. Konieczny, R.P. Lowry, F.K. Baddoura, and F.G. Lakkis. 1996. Acute rejection of vascularized heart allografts in the absence of IFNγ. Transplantation (Baltimore). 62:1908-1911.